LONDON (Reuters) - A rogue Chinese scientist who caused outrage last year when he said he had created the world’s first “gene-edited” babies in an attempt to protect them from HIV may also have put them at risk with a “foolish” choice of gene, experts said on Monday.

FILE PHOTO: Scientist He Jiankui speaks at his company Direct Genomics in Shenzhen, Guangdong province, China July 18, 2017. Picture taken July 18, 2017. REUTERS/Stringer

He Jiankui, then an associate professor at the Southern University of Science and Technology in Shenzhen, China, sparked an international scientific and ethical row when he said he had used a technology known as CRISPR-Cas9 to alter the embryonic genes of twin girls born in November 2018.

He said he had targeted a gene known as CCR5 and edited it in a way he believed would protect the girls from infection with HIV, the virus that causes AIDS.

But in a study published in the journal Nature Medicine on Monday, scientists found that people who have two copies of a so-called “Delta 32” mutation of CCR5 - which protects against HIV infection in some people - also have a significantly higher risk of premature death.

The researchers, Xinzhu Wei and Rasmus Nielsen of the University of California, Berkeley, said their findings showed the unintended consequences of introducing mutations in humans.

Robin Lovell-Badge, a leading geneticist and the organizer of a conference where He Jiankui made his revelation, said the results showed the Chinese scientist “was foolish to choose CCR5 to mutate in his attempts at germline genome editing”.

“We simply do not yet know enough about the gene,” said Lovell-Badge, a professor and gene expert at Britain’s Francis Crick Institute.

He Jiankui could not immediately be reached for comment.

Other specialists agreed the findings underline a need for extreme caution when considering possible human applications of gene editing technologies.

“This study should act as a stark warning that manipulation of the human genome with the aim of reducing susceptibility to specific diseases is not without considerable risk,” said Andrew Freedman, an infectious diseases expert at Cardiff University.

The Berkeley team’s study analyzed genotype and death register details from more than 400,000 people registered at the UK Biobank - an database of health and genetic information.

They found that people who have two copies of the Delta 32 mutation are about 20% less likely to reach age 76 compared with people who have one or no copies.

Chinese authorities immediately denounced He when he made his claim last year, and issued a temporary halt to research activities involving the editing of human genes. He was fired after a subsequent Chinese health commission investigation found he had “deliberately evaded oversight”.